Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 January 2018 Photo Charl Devenish
Researcher tackling drug-resistant TB through molecular methods
Dr Anneke van der Spoel van Dijk is invested in contributing to the global effort of stopping TB by 2035.

The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB). 

She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB). 

Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.

Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”

Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”

As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.

News Archive

TV star calls for dialogue on gender empowerment
2014-04-01


Jo-Anne Reyneke giving students and staff a talk from the heart.

TV star Jo-Anne Reyneke – previously known as 'Pearl' in Muvhango (SABC 2) and now 'Prudence' in Rhythm City (etv) – warned Qwaqwa Campus students to be careful of the things they say. She was speaking during the recent launch of the Qwaqwa Campus Gender Forum.

“As young people, you must learn to always truly listen and understand what your friends say. You must also be careful of the things you say, as you might prevent or be the cause of your friend's suicide, if you are not careful. What might seem like a small thing might have far-reaching results for you and your friend.

“Respect those who are different from you, as all of us would like to be accepted as we are. Carry yourself in a manner that shows you love yourself – and this starts with you respecting yourself and those who are different from you,” said Reyneke.

Reyneke also acknowledged that growing up was not easy for her, since she was labelled 'a Zulu-speaking white' due to her light complexion.

“I am glad that this campus has this kind of forum which will enable all – victims and perpetrators – to come together and share their experiences. This will further promote healing, reconciliation and unity.”

The Gender Forum is tasked with encouraging dialogue on matters that concern gender sensitivity and equality. It encourages both staff and students to break their silence and to create an environment of tolerance based on respect for human dignity and inclusiveness. The forum is constituted by various stakeholders with special skills in counselling, facilitation and empowerment in general.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept